// App-Quantinova.ai

2971 : Optides (optimized knottin peptides) computationally designed to target the oncogenic HIPPO pathway

Researchers

Presenter

  • Zachary R. Crook

Principal Investigators

  • Philip Bradley

  • Chris King

  • Andrew J. Mhyre

  • David Baker

  • James M. Olson

Medical Centers

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • University of Washington, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Yes Associated Protein 1

Drug/Treatment

  • TM-601

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved